Telomere dysfunction and evolution of intestinal carcinoma in mice and humans
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Telomerase activation is a common feature of advanced human cancers and facilitates the malignant transformation of cultured human cells and in mice. These experimental observations are in accord with the presence of robust telomerase activity in more advanced stages of human colorectal carcinogenesis. However, the occurrence of colon carcinomas in telomerase RNA (Terc)-null, p53-mutant mice has revealed complex interactions between telomere dynamics, checkpoint responses and carcinogenesis. We therefore sought to determine whether telomere dysfunction exerts differential effects on cancer initiation versus progression of mouse and human intestinal neoplasia. In successive generations of ApcMin Terc-/- mice, progressive telomere dysfunction led to an increase in initiated lesions (microscopic adenomas), yet a significant decline in the multiplicity and size of macroscopic adenomas. That telomere dysfunction also contributes to human colorectal carcinogenesis is supported by the appearance of anaphase bridges (a correlate of telomere dysfunction) at the adenoma-early carcinoma transition, a transition recognized for marked chromosomal instability. Together, these data are consistent with a model in which telomere dysfunction promotes the chromosomal instability that drives early carcinogenesis, while telomerase activation restores genomic stability to a level permissive for tumor progression. We propose that early and transient telomere dysfunction is a major mechanism underly…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We monitored the anaphase bridge index (ABI), an in vivo biomarker of the degree of telomere dysfunction in dividing tissues that mirrors chromosomal fusion frequency, in successive mTerc -/ -generations (7, 30) (see Materials and Methods for definition of ABI).”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [30]
In the citing paper
“The GI crypts of lategeneration mTerc -/ -Ink4a / Arf + / + and -/ -mice exhibited equally high levels of apoptosis (Fig. 1 C ), comparable to that in late-generation mTerc -/ -tissues with intact p53 function (7, 30).”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [30]
In the citing paper
“This finding differs from that of the mTerc Apc Min model, wherein telomere dysfunction promotes the initiation of intestinal carcinomas but inhibits their progression (30).”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [30]
In the citing paper
“findings consistent with previous studies establishing that telomere dysfunction acts as a tumor suppressor when p53 function is intact (7, 8, 30, 48).”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [30]
In the citing paper
“Crosses of telomerase-deficient mice with various tumour model mice have demonstrated that critically short telomeres limit tumour formation when the p53 pathway is functional51–55.”
From Telomeres in cancer: tumour suppression and genome instability (2017) · cites this paper as [52]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 1×
“gif" NDATA ITEM> ]> Telomerase activation is a common feature of advanced human cancer”
Genetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168 · cited 1×
“Epithelial cancers occur infrequently in laboratory mice, and when they do occur they rarely exhibit the aberrant cytogenetic profiles typical of human carcinomas, such as severe aneuploidy and complex nonreciprocal translocation”
BackgroundCreation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345 · cited 1×
“and facilitates the malignant transformation of cultured human cell”
BackgroundTelomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108
Self-citationTRF2 Protects Human Telomeres from End-to-End Fusions
van Steensel, B., Smogorzewska, A., & de Lange, T. (1998) · Cell · doi:10.1016/s0092-8674(00)80932-0 · Cited by 1,709
Telomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650 · cited 1×
“Together, the presence of short telomeres in colorectal carcinom”
BackgroundTHE STABILITY OF BROKEN ENDS OF CHROMOSOMES IN ZEA MAYS
McClintock, B. (1941) · Genetics · doi:10.1093/genetics/26.2.234 · Cited by 1,596
A Dominant Mutation That Predisposes to Multiple Intestinal Neoplasia in the Mouse
Moser, A. R., Pitot, H. C., & Dove, W. F. (1990) · Science · doi:10.1126/science.2296722 · Cited by 1,591 · cited 1×
“In successive generations of Apc Min Terc −/− mic”
BackgroundMultiple Intestinal Neoplasia Caused by a Mutation in the Murine Homolog of the APC Gene
Su, L.-K., Kinzler, K. W., Vogelstein, B., Preisinger, A. C., Moser, A. R., Luongo, C., Gould, K. A., & Dove, W. F. (1992) · Science · doi:10.1126/science.1350108 · Cited by 1,536
Longevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
Rudolph, K. L., Chang, S., Lee, H.-W., Blasco, M., Gottlieb, G. J., Greider, C., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80580-2 · Cited by 1,349
Self-citation
Cited by
Cytokinesis-block micronucleus cytome assay
Fenech, M. (2007) · Nature Protocols · doi:10.1038/nprot.2007.77 · Cited by 2,019
Telomeres and human disease: ageing, cancer and beyond
Blasco, M. A. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1656 · Cited by 1,434
“This supports the idea that short telomeres suppress carcinogenesis even in the absence of the main tumour-suppressor pathway”
BackgroundBonassi, S., Znaor, A., Ceppi, M., Lando, C., Chang, W. P., Holland, N., Kirsch-Volders, M., Zeiger, E., Ban, S., Barale, R., et al. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl177 · Cited by 1,023
“The most frequent cancer sites were colon and rectum (37), stomach (35), lung ( 28 ) and breast (20), mostly contributed by Japan, Italy and Sweden where the person-years were the largest and the mean ages of the cohorts were the highest.”
BackgroundGenomic and Epigenetic Instability in Colorectal Cancer Pathogenesis
Grady, W. M., & Carethers, J. M. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.076 · Cited by 960
The Chromosomal Instability Pathway in Colon Cancer
Pino, M. S., & Chung, D. C. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.065 · Cited by 932
Telomeres and telomerase in cancer
Artandi, S. E., & DePinho, R. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp268 · Cited by 823
Self-citationChromosome aberrations in solid tumors
Albertson, D. G., Collins, C., McCormick, F., & Gray, J. W. (2003) · Nature Genetics · doi:10.1038/ng1215 · Cited by 812
“Another form of chromosome instability may occur if tumors originate in somatic cells with inactive telomeras”
BackgroundTelomere length, stem cells and aging
Blasco, M. A. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.38 · Cited by 747
Telomeres in cancer: tumour suppression and genome instability
Maciejowski, J., & de Lange, T. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.171 · Cited by 745
Senescence and immortalization: Role of telomeres and telomerase
Shay, J. W., & Wright, W. E. (2005) · Carcinogenesis · doi:10.1093/carcin/bgh296 · Cited by 610
Evolution of the cancer genome
Yates, L. R., & Campbell, P. J. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3317 · Cited by 640
Telomeres: history, health, and hallmarks of aging
Chakravarti, D., LaBella, K. A., & DePinho, R. A. (2021) · Cell · doi:10.1016/j.cell.2020.12.028 · Cited by 637
“For example, in the intestinal adenoma of adenomatous polposis coli (APC); TERC-null mousemodel, telomere dysfunction initially increases adenoma frequency but ultimately constrains progression to macroadenomas and increases survival (Rudolph et al., 2001).”
BackgroundSelf-citationGenetic and biological hallmarks of colorectal cancer
Li, J., Ma, X., Chakravarti, D., Shalapour, S., & DePinho, R. A. (2021) · Genes & Development · doi:10.1101/gad.348226.120 · Cited by 573
“…sustains inactivating mutations or deletion of TP53 (which may be dispensable [Janssen et al. 2006]) with telomere dysfunction and double-stranded DNA breakage driving CIN (Rudolph et al. 2001), and invasive/metastatic disease often shows activating mutations in KRAS (Boutin et al. 2017).”
BackgroundInfluentialSelf-citationConnecting Chromosomes, Crisis, and Cancer
Maser, R. S., & DePinho, R. A. (2002) · Science · doi:10.1126/science.297.5581.565 · Cited by 561
Self-citationHepatocyte telomere shortening and senescence are general markers of human liver cirrhosis
WIEMANN, S. U., SATYANARAYANA, A., TSAHURIDU, M., TILLMANN, H. L., ZENDER, L., KLEMPNAUER, J., FLEMMING, P., FRANCO, S., BLASCO, M. A., MANNS, M. P., et al. (2002) · The FASEB Journal · doi:10.1096/fj.01-0977com · Cited by 527
“It has been shown that telomere shortening inhibits tumorigenesis in mTERC / mice that retain functional p53 (17, 32, 33).”
BackgroundSelf-citationCriteria for Inference of Chromothripsis in Cancer Genomes
Korbel, J. O., & Campbell, P. J. (2013) · Cell · doi:10.1016/j.cell.2013.02.023 · Cited by 538
Hallmarks of senescence in carcinogenesis and cancer therapy
Shay, J. W., & Roninson, I. B. (2004) · Oncogene · doi:10.1038/sj.onc.1207518 · Cited by 502
Telomere Dysfunction: A Potential Cancer Predisposition Factor
Wu, X., Amos, C. I., Zhu, Y., Zhao, H., Grossman, B. H., Shay, J. W., Luo, S., Hong, W. K., & Spitz, M. R. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg011 · Cited by 494
“In fact, telomere dysfunction (short telomeres) has been associated with the initiation and progression of mouse and human intestinal neoplasia ( 7 ).”
BackgroundTelomere length and risk of incident cancer and cancer mortality
Willeit, P., Willeit, J., Mayr, A., Weger, S., Oberhollenzer, F., Brandstätter, A., Kronenberg, F., & Kiechl, S. (2010) · JAMA · doi:10.1001/jama.2010.897 · Cited by 484
“While telomere elongation is a common molecular feature of advanced malignancies, there are several lines of evidence from experimental animals, basic research, genome-wide association studies, and rare disorders of telomere maintenance(1-5) suggesting that short telomeres and concurrent chromosomal instability contri…”
BackgroundDifferent telomere damage signaling pathways in human and mouse cells
Smogorzewska, A., & de Lange, T. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf433 · Cited by 482
“, 2000) and intestinal carcinomas in the ApcMin mouse (Rudolph et al., 2001).”
BackgroundTelomeres, stem cells, senescence, and cancer
Sharpless, N. E., & DePinho, R. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20761 · Cited by 473
Self-citationFarvid, M. S., Sidahmed, E., Spence, N. D., Mante Angua, K., Rosner, B. A., & Barnett, J. B. (2021) · European Journal of Epidemiology · doi:10.1007/s10654-021-00741-9 · Cited by 447
“Increased red meat or processed meat consumption has been shown to be associated with shorter telomere length [215, 216], which in turn result in chromosomal instability and promoting cancer risk [217, 218].”
BackgroundFenech, M. (2006) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2006.05.028 · Cited by 466
Choudhury, A. R., Ju, Z., Djojosubroto, M. W., Schienke, A., Lechel, A., Schaetzlein, S., Jiang, H., Stepczynska, A., Wang, C., Buer, J., et al. (2007) · Nature Genetics · doi:10.1038/ng1937 · Cited by 426
Self-citationPutting the stress on senescence
Serrano, M., & Blasco, M. A. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00278-7 · Cited by 413
Telomere dysfunction and tumour suppression: the senescence connection
Deng, Y., Chan, S. S., & Chang, S. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2393 · Cited by 411
“The link between telomere shortening and tumour suppression is further highlighted in the Terc −/− ; Apc Min mous”
BackgroundDNA damage checkpoints in stem cells, ageing and cancer
Sperka, T., Wang, J., & Rudolph, K. L. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3420 · Cited by 393
Self-citationChromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers
Maser, R. S., Choudhury, B., Campbell, P. J., Feng, B., Wong, K.-K., Protopopov, A., O’Neil, J., Gutierrez, A., Ivanova, E., Perna, I., et al. (2007) · Nature · doi:10.1038/nature05886 · Cited by 377
Self-citationTelomere Shortening Is Nearly Universal in Pancreatic Intraepithelial Neoplasia
van Heek, N. T., Meeker, A. K., Kern, S. E., Yeo, C. J., Lillemoe, K. D., Cameron, J. L., Offerhaus, G. J. A., Hicks, J. L., Wilentz, R. E., Goggins, M. G., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64432-x · Cited by 363
“The importance of CIN as an early driving force in carcinogenesis has been demonstrated in epithelial malignancies, such as colorectal cancers, in which anaphase bridges and allelic imbalance can be seen at the adenoma stage, which are the precursors to invasive cancer.(12,26) Although there are many potential causes…”
BackgroundIn situ analyses of genome instability in breast cancer
Chin, K., de Solorzano, C. O., Knowles, D., Jones, A., Chou, W., Rodriguez, E. G., Kuo, W.-L., Ljung, B.-M., Chew, K., Myambo, K., et al. (2004) · Nature Genetics · doi:10.1038/ng1409 · Cited by 361
“and are almost always eliminated by damage-surveillance mechanism”
BackgroundCancer Modeling in the Modern Era
Van Dyke, T., & Jacks, T. (2002) · Cell · doi:10.1016/s0092-8674(02)00621-9 · Cited by 358
Natural and pharmacological regulation of telomerase
Mergny, J.-L. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.4.839 · Cited by 352
Genomic instability and colon cancer
Grady, W. M. (2004) · Cancer and Metastasis Reviews · doi:10.1023/a:1025861527711 · Cited by 353
“Consistent with this model, human colon cancers show a peak in the anaphase bridge index, which is a measure of the number of metaphases that contain anaphase bridges, in early high-grade dysplastic lesions and less in more advanced carcinoma stages [118].”
ResultChromosomal instability in ulcerative colitis is related to telomere shortening
O'Sullivan, J. N., Bronner, M. P., Brentnall, T. A., Finley, J. C., Shen, W.-T., Emerson, S., Emond, M. J., Gollahon, K. A., Moskovitz, A. H., Crispin, D. A., et al. (2002) · Nature Genetics · doi:10.1038/ng989 · Cited by 346
“They are a hallmark of telomere dysfunction and can lead to chromosomal losses, gains and rearrangements after breakag”
BackgroundFerguson, L. R., Chen, H., Collins, A. R., Connell, M., Damia, G., Dasgupta, S., Malhotra, M., Meeker, A. K., Amedei, A., Amin, A., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.005 · Cited by 336
“lethal levels in the transforming cells, thereby presenting a second block to the development of cancer [37–40].”
Telomerase: A target for cancer therapeutics
Shay, J. W., & Wright, W. E. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00159-9 · Cited by 339
Constitutive telomerase expression promotes mammary carcinomas in aging mice
Artandi, S. E., Alson, S., Tietze, M. K., Sharpless, N. E., Ye, S., Greenberg, R. A., Castrillon, D. H., Horner, J. W., Weiler, S. R., Carrasco, R. D., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112515399 · Cited by 317
Self-citationShort Telomeres Limit Tumor Progression In Vivo by Inducing Senescence
Feldser, D. M., & Greider, C. W. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.026 · Cited by 314
Mathon, N. F., & Lloyd, A. C. (2001) · Nature Reviews Cancer · doi:10.1038/35106045 · Cited by 308
“The most dramatic illustration of the opposing effects that telomere shortening can have on tumour incidence is seen in Apc Min mic”
BackgroundThe nature of telomere fusion and a definition of the critical telomere length in human cells
Capper, R., Britt-Compton, B., Tankimanova, M., Rowson, J., Letsolo, B., Man, S., Haughton, M., & Baird, D. M. (2007) · Genes & Development · doi:10.1101/gad.439107 · Cited by 294
“Thus, short dysfunctional telomeres can drive the earliest stages of cancer; indeed, telomere dysfunction has been proposed to contribute to the nonreciprocal translocations that are common in adult carcinomas (Atkin 1986; Gisselsson et al. 2001, 2004; Rudolph et al. 2001).”
BackgroundConditional mouse models of sporadic cancer
Jonkers, J., & Berns, A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc777 · Cited by 294
Antitelomerase Therapy Provokes ALT and Mitochondrial Adaptive Mechanisms in Cancer
Hu, J., Hwang, S. S., Liesa, M., Gan, B., Sahin, E., Jaskelioff, M., Ding, Z., Ying, H., Boutin, A. T., Zhang, H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.028 · Cited by 296
“…rampant chromosomal instability (even in p53 null cells) compromises cellular viability (Begus-Nahrmann et al., 2009; Chin et al., 1999) and constrains full malignant progression of such cancers (Artandi et al., 2000; Chang et al., 2003; Gonzá lez-Suá rez et al., 2000; Rudolph et al., 2001).”
Self-citationKaryotypic complexity of the NCI-60 drug-screening panel.
Roschke, A. V., Tonon, G., Gehlhaus, K., Mctyre, N., Bussey, K. J., Lababidi, S., Scudiero, D. A., Weinstein, J. N., & Kirsch, I. R. (2003) · PubMed · Cited by 316
Ju, Z., Jiang, H., Jaworski, M., Rathinam, C., Gompf, A., Klein, C., Trumpp, A., & Rudolph, K. L. (2007) · Nature Medicine · doi:10.1038/nm1578 · Cited by 284
“It remains to be investigated whether environmental changes in response to telomere dysfunction might contribute to the increased cancer initiation that has been observed in aging telomere-dysfunctional mic”
BackgroundSelf-citationResolution of anaphase bridges in cancer cells
Hoffelder, D., Luo, L., Burke, N., Watkins, S., Gollin, S., & Saunders, W. (2004) · Chromosoma · doi:10.1007/s00412-004-0284-6 · Cited by 280
“Anaphase bridges have been strongly linked to chromosomal instability in human tumor samples (Fouladi et al. 2000; Gisselsson 2003; Montgomery et al. 2003) and tumorigenesis in mice (Artandi et al. 2000; Rudolph et al. 2001).”
BackgroundTelomere biology in healthy aging and disease
Oeseburg, H., de Boer, R. A., van Gilst, W. H., & van der Harst, P. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0728-1 · Cited by 269
“However, when the p53 pathway is inadequate tumorigenesis is no longer inhibited in the presence of telomere dysfunction [25, 34, 69].”
BackgroundTelomere shortening is an early somatic DNA alteration in human prostate tumorigenesis.
Meeker, A. K., Hicks, J. L., Platz, E. A., March, G. E., Bennett, C., Delannoy, M. J., & Marzo, A. M. D. (2002) · PubMed · Cited by 313
The Role of Aneuploidy in Cancer Evolution
Sansregret, L., & Swanton, C. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a028373 · Cited by 266
“2002), colon (Rudolph et al. 2001), and pancreas (Chin et al.”
BackgroundCellular senescence in vivo: a barrier to tumorigenesis
Prieur, A., & Peeper, D. S. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.01.007 · Cited by 260
Short Telomeres are Sufficient to Cause the Degenerative Defects Associated with Aging
Armanios, M., Alder, J. K., Parry, E. M., Karim, B., Strong, M. A., & Greider, C. W. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.10.028 · Cited by 257
APC and Its Modifiers in Colon Cancer
Kwong, L. N., & Dove, W. F. (2009) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4419-1145-2_8 · Cited by 254
Taketo, M. M., & Edelmann, W. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.049 · Cited by 249
Telomere dysfunction provokes regional amplification and deletion in cancer genomes
O'Hagan, R. C., Chang, S., Maser, R. S., Mohan, R., Artandi, S. E., Chin, L., & DePinho, R. A. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00094-6 · Cited by 246
“The analysis of human cultured cells in crisis (Counter et al., 1992), evolving human colorectal cancers (Hastie et al., 1990; Chadeneau et al., 1995; Rudolph et al., 2001 ), engineered telomeric double strand breaks in mouse embryonic stem cells (Lo et al., 2002), and tumors arising in mice with telomere dysfunction…”
BackgroundSelf-citationBalancing instability: dual roles for telomerase and telomere dysfunction in tumorigenesis
Hackett, J. A., & Greider, C. W. (2002) · Oncogene · doi:10.1038/sj.onc.1205061 · Cited by 246
“Insight into the relationship between genomic instability and tumor suppression in response to short telomeres comes from studies of telomere dysfunction in the ApcMin mouse (Rudolph et al., 2001).”
BackgroundOpposing effects of DNA hypomethylation on intestinal and liver carcinogenesis
Yamada, Y., Jackson-Grusby, L., Linhart, H., Meissner, A., Eden, A., Lin, H., & Jaenisch, R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506612102 · Cited by 245
Telomeres, chromosome instability and cancer
Bailey, S. M. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl303 · Cited by 243
“Therefore, although chromosomal rearrangements due to telomere loss in cancer cells are commonly thought to result from the extensive chromosome fusion that occurs during crisis (146,147), a high rate of telomere loss is often observed even in human tumors and tumor cell lines that express telomerase (73,140,144,148,1…”
BackgroundSuram, A., Kaplunov, J., Patel, P. L., Ruan, H., Cerutti, A., Boccardi, V., Fumagalli, M., Di Micco, R., Mirani, N., Gurung, R. L., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.132 · Cited by 227
“While the reasons for these differences are currently unknown, it is tempting to speculate that the decreased sensitivity to dysfunctional telomeres is a feature of cells in highly proliferative tissues such as colon and breast.”
Aoki, K., Tamai, Y., Horiike, S., Oshima, M., & Taketo, M. M. (2003) · Nature Genetics · doi:10.1038/ng1265 · Cited by 224
“Consistent with this, a mutation in DNA helicase or telomerase in Apc Min mice increases the number of intestinal polyps because of high frequency of recombination and chromosomal instabilit”
Telomere dysfunction and the initiation of genome instability
Feldser, D. M., Hackett, J. A., & Greider, C. W. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1142 · Cited by 225
“In telomerase-deficient mice, short dysfunctional telomeres can increase the frequency of tumorigenesi”
BackgroundDing, Z., Wu, C.-J., Jaskelioff, M., Ivanova, E., Kost-Alimova, M., Protopopov, A., Chu, G. C., Wang, G., Lu, X., Labrot, E. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.039 · Cited by 220
“Telomere dynamics contribute to human epithelial cancers as evidenced by coincidental telomere erosion, anaphase bridging, and chromosomal instability in early stages of carcinogenesis in the colon (Rudolph et al., 2001), prostate (Meeker et al.”
InfluentialSelf-citationTelomere length is reset during early mammalian embryogenesis
Schaetzlein, S., Lucas-Hahn, A., Lemme, E., Kues, W. A., Dorsch, M., Manns, M. P., Niemann, H., & Rudolph, K. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402400101 · Cited by 217
Self-citationMammalian Ku86 mediates chromosomal fusions and apoptosis caused by critically short telomeres
Espejel, S. (2002) · The EMBO Journal · doi:10.1093/emboj/21.9.2207 · Cited by 217
Telomere Dynamics in Mice and Humans
Calado, R. T., & Dumitriu, B. (2013) · Seminars in Hematology · doi:10.1053/j.seminhematol.2013.03.030 · Cited by 214
The contribution of farm animals to human health
KUES, W. (2004) · Trends in Biotechnology · doi:10.1016/j.tibtech.2004.04.003 · Cited by 168
Hallmarks of telomeres in ageing research
Shay, J., & Wright, W. (2007) · The Journal of Pathology · doi:10.1002/path.2090 · Cited by 211
Telomere length and the risk of lung cancer
Jang, J. S., Choi, Y. Y., Lee, W. K., Choi, J. E., Cha, S. I., Kim, Y. J., Kim, C. H., Kam, S., Jung, T. H., & Park, J. Y. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00831.x · Cited by 210
Exercise and the Hallmarks of Cancer
Ruiz-Casado, A., Martín-Ruiz, A., Pérez, L. M., Provencio, M., Fiuza-Luces, C., & Lucia, A. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.04.007 · Cited by 198
Role of APC and DNA mismatch repair genes in the development of colorectal cancers.
Narayan, S., & Roy, D. (2003) · Molecular Cancer · doi:10.1186/1476-4598-2-41 · Cited by 244
“Furthermore, telomere dysfunction has been shown to promote CIN that triggered early carcinogenesis in the ApcMin/+ Terc-/- mouse models, while telomerase activation restored genomic stability to a level permissive for tumor progression [77].”
BackgroundHarley, C. B. (2002) · Oncogene · doi:10.1038/sj.onc.1205076 · Cited by 150
“Progression of telomerase-negative tumors with short telomeres is clearly compromized in telomerase knockout mice (Rudolph et al., 2001), as it appears to be in humans.”
BackgroundBajaj, S., Asati, V., Singh, J., & Roy, P. P. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.04.051 · Cited by 187
Pathways connecting telomeres and p53 in senescence, apoptosis, and cancer
Artandi, S. E., & Attardi, L. D. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.211 · Cited by 191
Stewénius, Y., Gorunova, L., Jonson, T., Larsson, N., Höglund, M., Mandahl, N., Mertens, F., Mitelman, F., & Gisselsson, D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408454102 · Cited by 182
Telomere-related Genome Instability in Cancer
DE LANGE, T. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.032 · Cited by 182
Aging-Induced Stem Cell Mutations as Drivers for Disease and Cancer
Adams, P. D., Jasper, H., & Rudolph, K. L. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.05.002 · Cited by 180
“Studies from yeast to mammals provided experimental evidence for this interrelationship (Begus-Nahrmann et al., 2009; Hackett and Greider, 2003; Rudolph et al., 2001, Seluanov et al., 2004).”
BackgroundSelf-citationLin, T. T., Letsolo, B. T., Jones, R. E., Rowson, J., Pratt, G., Hewamana, S., Fegan, C., Pepper, C., & Baird, D. M. (2010) · Blood · doi:10.1182/blood-2010-02-272104 · Cited by 178
Telomeres and chromosome instability
Murnane, J. P. (2006) · DNA Repair · doi:10.1016/j.dnarep.2006.05.030 · Cited by 175
NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinoma
Wilson, C. L., Jurk, D., Fullard, N., Banks, P., Page, A., Luli, S., Elsharkawy, A. M., Gieling, R. G., Chakraborty, J. B., Fox, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms7818 · Cited by 171
Apc mice: Models, modifiers and mutants
McCart, A. E., Vickaryous, N. K., & Silver, A. (2008) · Pathology - Research and Practice · doi:10.1016/j.prp.2008.03.004 · Cited by 169
Lo, A. W. L., Sabatier, L., Fouladi, B., Pottier, G., Ricoul, M., & Mumane, J. P. (2002) · Neoplasia · doi:10.1038/sj.neo.7900267 · Cited by 169
“passage tumor cells [26] and tumors [41].”
BackgroundAPOBEC3-dependent kataegis and TREX1-driven chromothripsis during telomere crisis
Maciejowski, J., Chatzipli, A., Dananberg, A., Chu, K., Toufektchan, E., Klimczak, L. J., Gordenin, D. A., Campbell, P. J., & de Lange, T. (2020) · Nature Genetics · doi:10.1038/s41588-020-0667-5 · Cited by 167
Stop pulling my strings — what telomeres taught us about the DNA damage response
Lazzerini-Denchi, E., & Sfeir, A. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.43 · Cited by 170
Poly(ADP-ribose) polymerase: a guardian angel protecting the genome and suppressing tumorigenesis
Tong, W.-M., Cortes, U., & Wang, Z.-Q. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(01)00035-x · Cited by 163
The Role of Telomere Biology in Cancer
Xu, L., Li, S., & Stohr, B. A. (2013) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-164030 · Cited by 160
Sabatier, L., Ricoul, M., Pottier, G., & Murnane, J. P. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-04-0194 · Cited by 160
“However, mice deficient in both telomerase and p53 show a dramatic increase in the frequency of carcinomas that are similar to those seen in humans (14, 38).”
BackgroundFarazi, P. A., Glickman, J. N., Jiang, S., Yu, A., Rudolph, K. L., & DePinho, R. A. (2003) · PubMed · Cited by 201
Self-citationTransformation of normal human cells in the absence of telomerase activation
Seger, Y. R., Garcı́a-Cao, M., Piccinin, S., Cunsolo, C. L., Doglioni, C., Blasco, M. A., Hannon, G. J., & Maestro, R. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00183-6 · Cited by 159
“…and to spontaneous tumor development in both p16/ p19ARF and APCmin mutant backgrounds (Greenberg et al.,However, recent reports suggest that these are not critical func- tions of large T, at least in the presence of small t-antigen (Hahn 1999; González-Suárez et al., 2000; Rudolph et al., 2001).”
BackgroundChromosome rearrangements resulting from telomere dysfunction and their role in cancer
Murnane, J. P., & Sabatier, L. (2004) · BioEssays · doi:10.1002/bies.20125 · Cited by 179
“More recent studies, however, have shown that B/F/B cycles leading to DNAamplification do occur inmouse((23,24,37)) andhumancells.”
InfluentialTelomeres and telomerase: A dual role in hepatocarcinogenesis
Satyanarayana, A., Manns, M. P., & Rudolph, L. K. (2004) · Hepatology · doi:10.1002/hep.20308 · Cited by 158
Self-citationTelomerase, senescence and ageing
Shawi, M., & Autexier, C. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.11.007 · Cited by 170
Mann, M. B. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi075 · Cited by 159
“The Apc allele creates a sensitized background that is useful to evaluate the effect of specific genetic mutations on gastrointestinal tumor susceptibility in the mouse (37,38).”
BackgroundDjojosubroto, M. W., Chin, A. C., Go, N., Schaetzlein, S., Manns, M. P., Gryaznov, S., Harley, C. B., & Rudolph, L. K. (2005) · Hepatology · doi:10.1002/hep.20822 · Cited by 151
Self-citationLong telomeres and cancer risk: the price of cellular immortality
McNally, E. J., Luncsford, P. J., & Armanios, M. Y. (2019) · Journal of Clinical Investigation · doi:10.1172/jci120851 · Cited by 167
“Similar patterns have also been seen in cancer-prone models in which cancers are inducible by loss of a tumor suppressor such as ApcMin or Ink4a (93, 94).”
ResultHydrophobic bile acids, genomic instability, Darwinian selection, and colon carcinogenesis
Payne, C. M., Bernstein, C., Dvorak, K., & Bernstein, H. (2008) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s4343 · Cited by 158
“…kinetochore-microtubule attachment defects, 161,162 failure of DNA damage checkpoints, 163 failure of spindle checkpoints, 164–166 telomere defects 167,168 and aberrant centrosomal organization and multiplicity 169,170 may result in an incorrect number of chromosomes in daughter cells after…”
Mice with bad ends: mouse models for the study of telomeres and telomerase in cancer and aging
Blasco, M. A. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600598 · Cited by 164
“…in tumor suppressor genes other than p53 significantly reduce carcinogenesis (Chin et al, 1999; Greenberg et al, 1999; Artandi et al, 2000; Rudolph et al, 2001; Wong et al, 2003), suggesting that a telomerase inhibitor may be &2005 European Molecular Biology Organization The EMBO Journal…”
BackgroundTelomeres and Telomerase in Aging, Regeneration and Cancer
Djojosubroto, M. W., Choi, Y. S., Lee, H., & Rudolph, K. L. (2003) · Molecules and Cells · doi:10.1016/s1016-8478(23)13723-x · Cited by 172
Self-citationPlentz, R. R., Park, Y. N., Lechel, A., Kim, H., Nellessen, F., Langkopf, B. H. E., Wilkens, L., Destro, A., Fiamengo, B., Manns, M. P., et al. (2007) · Hepatology · doi:10.1002/hep.21552 · Cited by 167
Self-citationSchaetzlein, S., Nalapareddy, K., Ju, Z., Lechel, A., Stępczyńska, A., Lilli, D. R., Clark, A. B., Rudolph, C., Kühnel, F., Wei, K., et al. (2007) · Cell · doi:10.1016/j.cell.2007.08.029 · Cited by 167
Self-citationTherapeutic Targeting of Telomerase
Jäger, K., & Walter, M. (2016) · Genes · doi:10.3390/genes7070039 · Cited by 157
“By induction of telomere dysfunction and attrition chromosomal instability occurs and may result in activation of oncogenes and/or silencing of tumor suppressor genes, which may counteract the original therapeutic intention and cooperate to promote malignant transformation and drug resistance [248–252].”
BackgroundMunro, J., Barr, N. I., Ireland, H., Morrison, V., & Parkinson, E. K. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.01.017 · Cited by 141
Role of Telomeres and Telomerase in the Pathogenesis of Human Cancer
Hahn, W. C. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.018 · Cited by 156
“observations have also been made in mice deficient for both telomerase and adenomatous polyposis coli.(125) These observa-”
Background
Metadata
- Authors
- Rudolph, K. L., Millard, M., Bosenberg, M. W., & DePinho, R. A.
- Affiliations
- Dana-Farber Cancer Institute (US)
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Corresponding author
- DePinho, Ronald A.
- Venue
- Nature Genetics
- Published
- 2001-06
- Volume
- 28
- Issue
- 2
- Pages
- 155-159
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1483245334
- Cited by
- 527
- References
- 31
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 9 · 2023: 10 · 2022: 8 · 2021: 13 · 2020: 8 · 2019: 12 · 2018: 11 · 2017: 10 · 2016: 16 · 2015: 18 · 2014: 16 · 2013: 26 · 2012: 27
- FWCI
- 26.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- telomere dysfunction, telomerase activation, colorectal carcinogenesis, chromosomal instability, ApcMin/+ mice, TP53 mutation, anaphase bridges, tumor progression, tumor initiation, genome stability
- MeSH terms
- Adenocarcinoma, Adenoma, Animals, Cytoskeletal Proteins, Humans, Intestinal Neoplasms, Mice, Inbred C57BL, Mice, Mutant Strains, RNA, Colorectal Neoplasms, Tumor Suppressor Protein p53, Telomere, Apoptosis, Telomerase, Adenomatous Polyposis Coli Protein, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.